Decentralised immunological application where the United Kingdom is the reference member State
This section has no associated Explanatory Memorandum
10. The fee for a decentralised application for a marketing authorisation for an immunological product where the United Kingdom is the reference member State is the same as for a national application set out in the previous table, with the addition of the fees in the following table—
Decentralised immunological application where the United Kingdom is the reference member State
Application | Additional fee (£) |
---|---|
One member State | 3,470 |
Each additional member State | 530 |
Simultaneous applications: fee for each additional product in the application | |
| 6,670 |
| 120 |